Dr. Emil J Pecholt, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 608 Nw 7th St, Pocahontas, IA 50574 Phone: 712-335-5632 |
Ted P George, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 608 Nw 7th St, Pocahontas, IA 50574 Phone: 712-335-5632 |
Elizabeth Hemkens, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 22 3rd Ave Nw, Pocahontas, IA 50574 Phone: 712-335-7434 |
Eugene Mullins, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 608 Nw 7th St, Pocahontas, IA 50574 Phone: 712-335-5632 |
Jennifer E Boevers, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 608 Nw 7th St, Pocahontas, IA 50574 Phone: 712-335-5632 |
News Archive
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced that its abstract titled "ACH-1625 Demonstrates Sustained Viral Suppression in Presence of Uncommon Drug Resistant HCV Variants: Pharmacokinetic, Pharmacodynamic and Clinical Virology Analysis of Phase I Study" has been accepted as a late breaking poster presentation at the 61st Annual Meeting of the American Association for the Study of Liver Disease The Liver Meeting 2010 being held October 29-November 2, 2010 in Boston.
Ten-year-olds' free time activities - as well as whom they spend their free time with - are linked to gender development, academic interests, school grades and self esteem at age 12, a Penn State study shows.
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.
There are estimated to be between 50,000 - 100,000 individuals in the U.S. diagnosed with chronic Immune Thrombocytopenic Purpura (ITP), an autoimmune disease that dramatically reduces the number of platelets in their blood - causing bruises, nosebleeds and, sometimes, life-threatening brain hemorrhages.
› Verified 7 days ago